Multiple Manufacturers

CLINDAMYCIN PHOSPHATE IN NACL

Manufacturer:

Multiple Manufacturers

Clindamycin Phosphate In Nacl HCPCS:

J0737

HCPCS Code Descriptor:

Injection, clindamycin phosphate (baxter), not therapeutically equivalent to j0736, 300 mg

Category:

J Code

Clindamycin Phosphate In Nacl NDCs:

43066-0995-24, 00338-9553-24, 43066-0993-24, 00338-9549-24, 00338-9545-24

Primary Type:

Antibiotic

Generic/Specialty Status:

Multi-Source

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Clindamycin Phosphate In Nacl:

CLINDAMYCIN PHOSPHATE IN NACL is a Antibiotic drug manufactured by BAXTER HEALTHCARE CORP and administered via the Intravenous route of administration. The J Code: J0737 is aligned to the drug CLINDAMYCIN PHOSPHATE IN NACL.

ACCESS PRICING AND MORE BY REGISTERING

J0737 Added Date:

July 1, 2023

J0737 Effective Date:

July 1, 2023

J0737 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Clindamycin Phosphate In Nacl billing and coding information.
Our team did not identify a source for Clindamycin Phosphate In Nacl patient assistance information. Please reach out to our team if you feel that this is a mistake.
Our team is still working to identify a prescribing information source for CLINDAMYCIN PHOSPHATE IN NACL
Our team has not yet identified a source of side effects information for CLINDAMYCIN PHOSPHATE IN NACL. Please check back in a few weeks.